<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000648590"><TermName>fosaprepitant dimeglumine</TermName><TermPronunciation>(FOS-uh-PREH-pih-tunt dy-MEG-loo-meen)</TermPronunciation><TermDefinition><DefinitionText>A drug used together with other drugs to prevent and control nausea and vomiting caused by cancer treatment. It is given in a vein. It is a type of antiemetic and a type of substance P/neurokinin 1 receptor antagonist. Also called Emend for Injection.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000725682" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fosaprepitant dimeglumine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000725681" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fosaprepitant dimeglumina&quot;" language="es" id="_4"/><SpanishTermName>fosaprepitant dimeglumina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa junto con otros para prevenir y controlar la náusea y el vómito causados por el tratamiento de cáncer. Se administra a través de una vena. Es un tipo de antiemético y un tipo de antagonista del receptor de la sustancia P o neuroquinina 1. También se llama Emend por inyección.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-01-11</DateFirstPublished></GlossaryTerm>
